Organ-on-chip applications in drug discovery: an end user perspective

N Clapp, A Amour, WC Rowan… - Biochemical Society …, 2021 - portlandpress.com
… In recent years, commercially available OoCs have been increasingly integrated within
the drug development phase, to replace more traditional preclinical models (Figure 2; [3–6]). …

New and emerging research on solute carrier and ATP binding cassette transporters in drug discovery and development: outlook from the international transporter …

KM Giacomini, SW Yee, ML Koleske… - Clinical …, 2022 - Wiley Online Library
drug development, focusing largely on drugdrug interactions (DDIs), but also including other
topics relevant to the role of transporters in drug … The integration of time-resolved imaging …

Artificial intelligence in drug metabolism and excretion prediction: recent advances, challenges, and future perspectives

TTV Tran, H Tayara, KT Chong - Pharmaceutics, 2023 - mdpi.com
… processes is an essential part of drug discovery and development. In recent years, artificial
… Overall, we provided a comprehensive overview of recent AI-based drug metabolism and …

Emergent drug and nutrition interactions in COVID-19: a comprehensive narrative review

D Ağagündüz, MN Çelik, ME Çıtar Dazıroğlu… - Nutrients, 2021 - mdpi.com
… In this review, the possible mechanisms and pharmacokinetic and pharmacodynamic effects
of some pharmacological agents used in treating COVID-19 or alleviating its symptoms are …

Microfluidic technologies for drug discovery and development: friend or foe?

KS Elvira - Trends in Pharmacological Sciences, 2021 - cell.com
… into the drug discovery and development pipeline. Key learning objectives will include how
to minimize the disruption these technologies cause and how to integrate them with current …

High-throughput organ-on-chip platform with integrated programmable fluid flow and real-time sensing for complex tissue models in drug development workflows

H Azizgolshani, JR Coppeta, EM Vedula, EE Marr… - Lab on a Chip, 2021 - pubs.rsc.org
Drug development suffers from a lack of predictive and … In addition, we integrate electrical
sensors, demonstrating … and oxygen consumption via integrated oxygen sensors. Finally, we …

Lumbar cerebrospinal fluid-to-brain extracellular fluid surrogacy is context-specific: insights from LeiCNS-PK3. 0 simulations

MAA Saleh, CF Loo, J Elassaiss-Schaap… - … and Pharmacodynamics, 2021 - Springer
… ) drug development yet difficult due to ethical restrictions of human brain sampling. CNS
pharmacokinetic (PK… We previously published a comprehensive CNS physiologically-based PK (…

Toward Project Optimus for Oncology Precision Medicine: Multi‐Dimensional Dose Optimization Enabled by Quantitative Clinical Pharmacology.

K Venkatakrishnan… - Clinical Pharmacology & …, 2022 - search.ebscohost.com
drug development community and offered a call to action for reforming current approaches.
integrated in a mechanism- informed manner through modeling and simulation. Prior knowl- …

Microfluidics for drug development: from synthesis to evaluation

Y Liu, L Sun, H Zhang, L Shang, Y Zhao - Chemical reviews, 2021 - ACS Publications
… the entire process of drug development with an emphasis on … we believe that such a
comprehensive summary of this subject … drug development system, ie, from drug synthesis to drug

Berberine as a potential anticancer agent: A comprehensive review

A Rauf, T Abu-Izneid, AA Khalil, M Imran, ZA Shah… - Molecules, 2021 - mdpi.com
… Among alkaloids, isoquinoline alkaloids are known as natural plant products that have
demonstrated a considerable impact in drug discovery. Isoquinoline alkaloids are predominantly …